UGT8-IN-1 is an orally active, blood-brain barrier-penetrating small-molecule inhibitor that targets UGT8 (ceramide galactosyltransferase). By inhibiting pathways involved in sphingolipid synthesis, it is used in research into the mechanisms of neurological disorders such as lysosomal storage diseases.
Molekulargewicht:
528.47
Reinheit:
99.60%
CAS Nummer:
[2414349-93-0]
Formel:
C20H22F6N4O4S
Target-Kategorie:
UGT
T40046
T40046
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
